Efficacy of an accelerated hepatitis b vaccination program during pregnancy

Obstetrics and Gynecology

Volumn 117, Issue 5, 2011, Pages 1130-1135

  Sheffield, Jeanne S ^a   Hickman, Ashley ^b   Tang, Jennifer ^b   Moss, Kristie ^b   KouroS H , Atoosa ^b   Crawford, Natalie M ^b   Wendel, George D ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; BODY MASS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED HEADACHE; ERYTHEMA; FATIGUE; FEASIBILITY STUDY; FEMALE; FEVER; HEPATITIS B; HIGH RISK PREGNANCY; HUMAN; IMMUNOGENICITY; INJECTION SITE DISCOMFORT; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEROCONVERSION; SWELLING; VACCINATION; VOMITING;

ADULT; BIOLOGICAL MARKERS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; VACCINATION;

EID: 79955529541     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182148efe     Document Type: Article

References (25)

1. World Health Organization Fact Sheet No. 204. Hepatitis B. Available at: www.who.int/mediacentre/factsheets/fs204/en/. Retrieved October 18, 2010.
2. Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis- United States, 2007. MMWR Surveill Summ 2009;58:1-27.
3. Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, et al. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med 2009;150:104-10.
4. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40: 1-25.
5. Viral hepatitis in pregnancy. ACOG Practice Bulletin No. 86. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:941-56.
6. Hess G, Hingst V, Cseke J, Bock HL, Clemens R. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis 1992;11:334-40.
7. Bock HL, Löscher T, Scheiermann N, Baumgarten R, Wiese M, Dutz W, et al. Accelerated Schedule for Hepatitis B Immunization. J Travel Med 1995;2:213-7.
8. Van Herck K, Leuridan P, Van Damme P. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance. Sex Transm Infect 2007;83:426-32. (Pubitemid 350063839)
9. Wouters K, Leuridan E, Van Herck K, Van Ardenne N, Roelofs I, Mak R. Compliance and immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium. Vaccine 2007;25:1893-900. (Pubitemid 46176318)
10. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices part 2: immunization of adults. MMWR Morb Mortal Wkly Rep 2006;55(RR-16):1-25.
11. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents [published errata appear in MMWR Morb Mortal Wkly Rep 2006;55:158-9 and MMWR Morb Mortal Wkly Rep 2007;56:1267]. MMWR Recomm Rep 2005;54:1-31.
12. Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991;8:227-32.
13. Grosheide PM, Schalm SW, van Os HC, Fetter WP, Heijtink RA. Immune response to hepatitis B vaccine in pregnant women receive post-exposure prophylaxis. Eur J Obstet Gynecol Reprod Biol 1993;50:53-8. (Pubitemid 23197880)
14. Gupta I, Ratho RK. Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003;29:84-6. (Pubitemid 36575542)
15. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;336:196-204. (Pubitemid 27034966)
16. Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989;7:106-10. (Pubitemid 19089664)
17. Andre FE. Summary of safety and efficacy data on a yeastderived hepatitis B vaccine. Am J Med 1989;87:14S-20S.
18. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect 1986;13(suppl A):39-45.
19. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9. (Pubitemid 16206968)
20. Ingardia CJ, Kelley L, Steinfeld JD, Wax JR. Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstet Gynecol 1999;93:983-6. (Pubitemid 29247108)
21. Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. J Med Virol 2001;64:290-8. (Pubitemid 32565125)
22. Goldwater PN. Randomized, comparative trial of 20 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997;15:353-6. (Pubitemid 27156154)
23. Middleman AB, Anding R, Tung C. Effect of needle length when immunizing obese adolescents with hepatitis B vaccine. Pediatrics 2010;125:e508-12.
24. Dinelli MI, Moraes-Pinto MI. Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder. Rev Inst Med Trop Sao Paulo 2008;50:129-30. (Pubitemid 351744076)
25. Ahmed SM, Volpellier M, Forster G. The use of the super accelerated hepatitis B vaccination regimen in a north London sexual assault referral centre (SARC). J Forensic Leg Med 2007;14:72-4. (Pubitemid 46112445)